Safety of Regular-Dose Imatinib Therapy in Patients with Gastrointestinal Stromal Tumors Undergoing Dialysis

The number of cancer patients undergoing dialysis has been increasing, and the number of these patients on chemotherapy is also increasing. Imatinib is an effective and safe therapy for KIT-positive gastrointestinal stromal tumors (GIST), but the efficacy and safety of imatinib in dialysis patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Niikura, Ryota, Serizawa, Takako, Yamada, Atsuo, Yoshida, Shuntaro, Tanaka, Mariko, Hirata, Yoshihiro, Koike, Kazuhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4929395/
https://www.ncbi.nlm.nih.gov/pubmed/27403097
http://dx.doi.org/10.1159/000443267

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4929395/
https://www.ncbi.nlm.nih.gov/pubmed/27403097
http://dx.doi.org/10.1159/000443267

Ejemplares similares